Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Xylo Technologies Ltd (XYLO)

  • Technical Exchange News
  • Aug. 25, 2025, 07:24 UTC
  • 13
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Xylo Technologies Ltd. - American Depositary Shares.

Comment Full text

Sarepta Therapeutics Inc (SRPT)

  • Business News
  • Aug. 25, 2025, 07:11 UTC
  • 6
  • 0 comments

SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

Market reaction Comment Full text

Biogen Inc (BIIB)

  • Business News
  • Aug. 25, 2025, 07:01 UTC
  • 8
  • 0 comments

Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)

Market reaction Comment Full text

ArgenX Inc (ARGX)

  • Business News
  • Aug. 25, 2025, 05:00 UTC
  • 8
  • 0 comments

argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG

Market reaction Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • Aug. 25, 2025, 04:40 UTC
  • 8
  • 0 comments

[Press Release] HUTCHMED Announces Appointment of Acting Chief Executive Officer

Market reaction Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • Aug. 25, 2025, 04:34 UTC
  • 8
  • 0 comments

Ceasing to be a substantial holder

Market reaction Comment Full text

Aoxin Q & M Dental Grp Limited (1D4)

  • Business News
  • Aug. 25, 2025, 03:26 UTC
  • 9
  • 0 comments

Q & M Dental Group (Singapore) Limited - Announcement

Market reaction Comment Full text

Hyphens Pharma International Limited (1J5)

  • Business News
  • Aug. 25, 2025, 01:00 UTC
  • 9
  • 0 comments

PhillipCapital’s Equity Research – Bump in the Road, Scaling Up Journey Intact

Market reaction Comment Full text

Xylo Technologies Ltd (XYLO)

  • Technical Exchange News
  • Aug. 25, 2025, 00:25 UTC
  • 14
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Xylo Technologies Ltd. - American Depositary Shares.

Comment Full text

Xylo Technologies Ltd (XYLO)

  • Technical Exchange News
  • Aug. 25, 2025, 00:25 UTC
  • 15
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Xylo Technologies Ltd. - American Depositary Shares. New value: Xylo Technologies Ltd. - American Depositary Shares.

Comment Full text

Xylo Technologies Ltd (XYLO)

  • Technical Exchange News
  • Aug. 25, 2025, 00:25 UTC
  • 15
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Xylo Technologies Ltd. - American Depositary Shares.

Comment Full text

HUTCHMED DRC (HCM)

  • Business News
  • Aug. 25, 2025, 00:20 UTC
  • 9
  • 0 comments

HUTCHMED Announces Appointment of Acting Chief Executive Officer

Market reaction Comment Full text

Lantheus Holdings Inc. (LNTH)

  • Business News
  • Aug. 24, 2025, 22:03 UTC
  • 11
  • 0 comments

LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm

Market reaction Comment Full text

Sensus Healthcare Inc (SRTS)

  • Business News
  • Aug. 24, 2025, 21:34 UTC
  • 11
  • 0 comments

SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Aug. 24, 2025, 19:50 UTC
  • 12
  • 0 comments

The Best Mini PCs for Gaming

Market reaction Comment Full text
  • Previous
  • 333
  • 334
  • 335
  • 336
  • 337
  • Next

Search

News categories

  • Technical Exchange News(10036)
  • Event(412)
  • SEC News(169763)
  • FDA Approval(9408)
  • Company Report(721)
  • Business News(113063)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin